#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Familial dilated cardiomyopathy Hypersensitivity pneumonitis Systemic candida Dementia with Lewy bodies Idiopathic pulmonary fibrosis Bronchiolitis Ichthyosis Myxofibrosarcoma Hypoxic-ischaemic encephalopathy Congenital myopathy Neuronal ceroid lipofuscinosis Autoimmune demyelinating disease Cholestatic pruritus Microscopic polyangiitis More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Trials in Disease Ornithine transcarbamoylase deficiency – Basic Information Richter’s syndrome – Treatment Stevens-Johnson syndrome – Basic Information Marginal zone lymphoma refractory Cystic fibrosis lung – Treatment Choroid melanoma Angiosarcoma recurrent – Diagnostics Immunodeficiency congenital – Diagnostics Primary biliary cholangitis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cenerimod Golodirsen Burfiralimab Ibrutinib Gozetotide Nefopam Palmidrol Ucart22 Carisbamate Nimodipine Xylitol Arsenic Trioxide D5-Ethyl-Beta-D-Glucuronide Talquetamab Bi 1291583 Quc398 Mometasone Furoate Monohydrate Oteracil Pioglitazone Mitoxantrone More therapies…

    Learn about Your Condition

    Basal cell carcinoma Electrocorticogram Cardiac disorder Hepatic fibrosis Type IIa hyperlipidaemia Endocarditis enterococcal Testicular germ cell cancer Ureteric cancer Pulmonary alveolar haemorrhage Juvenile idiopathic arthritis B-cell lymphoma recurrent Parkinson's disease Acne Oedema Sjogren's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of CAPOX or FOLFOX chemotherapy before surgery in patients with obstructive colon cancer treated with colostomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • Study on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Colchicine
    France

  • Study on the Effects of Oxycodone and Paracetamol in Patients with Heart Valve or Coronary Artery Disease After Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic valve disease
    • Mitral valve disease
    • Tricuspid valve disease
    Investigated Drugs:
    • Oxycodone Hydrochloride
    • Paracetamol
    Finland

  • Study on Treating Knee Osteoarthritis with N-TEC Implant for Patients with Patellofemoral Osteoarthritis

    Recruiting

    2 1 1
    Investigated Drugs:
    • N-Tec
    Croatia Germany

  • Study on Axicabtagene Ciloleucel for Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma recurrent
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Fludarabine
    • Cyclophosphamide
    Spain

  • Study of Tabelecleucel for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Transplant Treatment Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epstein-Barr virus associated lymphoproliferative disorder
    • Post transplant lymphoproliferative disorder
    Investigated Drugs:
    • Tabelecleucel
    Austria Belgium France Italy Spain
Previous Page
1 … 382 383 384 385 386 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!